Intensity Therapeutics (INTS) Earnings Date & Reports

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

INTS is expected to report earnings to fall 12.00% to -21 cents per share on March 13

Intensity Therapeutics INTS Stock Earnings Reports

Q4'24

Est.

$-0.22

Q3'24

Beat

by $0.06

Q2'24

Missed

by $0.04

Q4'23

Missed

by $0.05

Q3'23

Missed

by $0.08

The last earnings report on November 13 showed earnings per share of -25 cents, beating the estimate of -30 cents. With 10.24K shares outstanding, the current market capitalization sits at 34.89M.

View a ticker or compare two or three

Compare

INTS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For INTS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

1 Enterprise Drive

Phone

+1 203 221-7381

Employees

Web

https://www.intensitytherapeutics.com